The numbers coming out of D-Wave Quantum tell two radically different stories, and investors are struggling to decide which one to believe. On one side sits a $33.4 million order book that grew nearly 2,000% year-over-year in the first quarter — a figure that would make most growth-stage tech companies envious. On the other sits a share price that has collapsed 60.23% from its October 2025 record of €38.48, with the stock now changing hands at around €15.30.
That tension between operational momentum and market sentiment has defined D-Wave’s journey through 2026. The quantum computing pioneer has watched its equity shed 32.46% since the start of the year, and the past 30 days alone have carved off 28.61% — a descent that has pulled IonQ and Rigetti down in near-lockstep.
When Policy Promises Meet Market Reality
The catalyst for the initial euphoria came on June 22, when Donald Trump signed two executive orders designating quantum computing as a strategic technology. D-Wave, IonQ and Rigetti all surged as investors priced in government backing and a wave of federal contracts. But mandates, as it turned out, are not the same as money. Once the market realized that statements of intent weren’t translating into purchase orders, the sell-off began in earnest.
External pressures compounded the problem. Rising tensions in the Middle East, climbing oil prices and deepening skepticism about the commercial readiness of quantum technology all landed on a company with thin revenues and no path to near-term profitability. The relative strength index now sits at 36.1, flirting with oversold territory, while annualized volatility above 78% underscores just how jittery the trading has become.
A Business Scaling Faster Than Its Losses
The uncomfortable truth for quantum optimists is that the fundamentals have never caught up with the valuation fantasies. D-Wave posted a loss per share of roughly minus $1.14 over the trailing twelve months, and not a single pure-play quantum computing stock trades on a positive price-to-earnings ratio. Without an earnings anchor, these names react violently to shifts in sentiment — exactly what investors are experiencing now.
But writing D-Wave off as pure hype misses the other half of the equation. The operating loss in the first quarter came in at $54.7 million, more than quadruple the $11.3 million recorded a year earlier. That sounds alarming until you consider why the loss is growing: the company is scaling, not stagnating. The $33.4 million in bookings for the quarter — a near-2,000% jump from the prior year — represents a record for the firm and a growth rate that is rare even among speculative tech names.
That disconnect is why some analysts still see a wide gap between price and potential. The consensus price target of €32.91 implies upside of roughly 115% from current levels, suggesting that the long-term thesis remains intact even as the short-term pain intensifies.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Insider Sales Raise Eyebrows Ahead of the Nasdaq Switch
The timing of the share price weakness has been particularly awkward. D-Wave is in the middle of moving its listing from the New York Stock Exchange to the Nasdaq, with trading on the NYSE ending after the close on July 24 and the stock expected to begin trading on the Nasdaq under the ticker QBTS on July 27. Management has framed the move as a strategic repositioning rather than a comment on near-term business performance.
Yet two senior executives have been selling shares in the run-up to the transition. Sophie C. Ames, Executive Vice President and Chief Human Resources Officer, disposed of 3,070 shares on July 20 at a weighted average price of $16.95 per share. The transaction was executed through a Rule 10b5-1 trading plan established in June 2025 and later amended, with the shares originating from RSU vesting on June 18. It was not Ames’ first sale this year — she had already offloaded 23,025 shares on May 20.
CEO Alan Baratz followed suit, selling 52,320 shares on July 14. D-Wave characterized that transaction as a non-discretionary move to cover tax obligations triggered by RSU vesting, not a conscious market call. Baratz still holds approximately 3.2 million shares directly, including 1,137,257 unexercised RSUs.
These insider sales are formally tied to tax liabilities and pre-arranged plans, not spontaneous bets against the company. But for investors already nursing losses from the recent rout, the optics are hard to ignore.
The Recurring Pattern of Early-Cycle Tech
The stock has recovered 37.57% from its 52-week low of €11.12 set in late March, only to give back those gains and slide again. For a name with deep losses and a valuation built almost entirely on future promises, every pullback tests whether investors are pricing in the long arc of quantum computing or simply trading its short-term mood.
The pattern is familiar from earlier tech cycles: a genuine technological narrative, real order growth and government interest colliding with a market that wants profits now. D-Wave is improving its fundamentals in absolute terms. But until the loss trajectory narrows enough to support a reasonable valuation metric, the stock will likely continue to trade less like a computer company and more like a leveraged bet on the eventual commercial breakthrough of quantum technology.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from July 22 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 22.
D-Wave Quantum: Buy or sell? Read more here...
